Elucid's FDA-cleared AI heart imaging tool shows 92.9% accuracy against invasive FFR in ELUCIDATE study
Presented at TCT 2026, the retrospective study covered 491 coronary vessels from 347 patients at 11 US and European sites and also reported strong accuracy in the 0.75 to 0.85 'gray zone'; it is company-announced data.